Cross icon
Contact us

Restoring mobility for a better quality of life

We are committed to bring first-in-class breakthrough therapies to patients suffering from osteoarthritis in the world.

Danseuse en apesanteur
This picture is illustrating the fact that one out of two adults will be affected by osteoarthritis in their lifetime

Patients-centric by essence

Nearly one out of two adults will be affected by osteoarthritis in their lifetime, making osteoarthritis the leading cause of disability in the world.

This picture is illustrating the development of a disease-modifying osteoarthritis drug

What we do? Innovative science

4Moving Biotech's team is developing 4P004, a disease-modifying osteoarthritis drug (DMOAD) candidate, a potential long-term solution for osteoarthritis patients.

Our latest news